i totally agree.

the stock seems very cheap relative to where we were just a few months ago - while at the same time, we know so much more about the drug's effectiveness and exactly how to create successful trials that the world will soon see.

i'm WAY over-exposed at this point (at least for me) and yet i have still been buying based on this. for new people (or people who have been trading in and out), i think this is a fantastic time.